Company Analysis

DBV Technologies S.A. (DBVT)

Nasdaq: DBVT · Biological Products, (No Diagnostic Substances) · Chatillon, FR · filing with the SEC since 2014
Grade4.8
◀ Past 3.7● Present 4.2▶ Future 6.0
1 est.

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

24 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to DBV Technologies S.A.’s names, not what it holds today.

Patents granted
24
18 utility, 6 design, 1976 to Dec 31, 2025
Granted in 2025
4
Against 4 in 2024 and 2 in 2023
Applications published
25
1 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'10'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals6
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
DBV TECHNOLOGIES its own name
FR, as the owner printed on each patent
24 granted
16 published
DBV TECHNOLOGIES its own name
named as the applicant on its applications, in FR
0 granted
9 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 30, 202512,508,608Method of depositing a substance on a substratePharmaceuticalsDBV TECHNOLOGIES
Sep 2, 202512,403,193Allergen desensitization methodPharmaceuticalsDBV TECHNOLOGIES
May 20, 2025D1,076,111Patch assemblyDBV TECHNOLOGIES
May 20, 2025D1,076,110Patch assemblyDBV TECHNOLOGIES
Mar 26, 202411,938,178Optimized epicutaneous vaccinationPharmaceuticalsDBV TECHNOLOGIES
Mar 19, 202411,931,411Allergen desensitization methodPharmaceuticalsDBV TECHNOLOGIES
Jan 23, 2024D1,012,297Patch assemblyDBV TECHNOLOGIES
Jan 23, 2024D1,012,296Patch assemblyDBV TECHNOLOGIES
Sep 19, 2023D999,385Patch assemblyDBV TECHNOLOGIES
Sep 19, 2023D999,384Patch assemblyDBV TECHNOLOGIES
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 11, 20252025/0375518ALLERGEN DESENSITIZATION METHODPharmaceuticalsDBV TECHNOLOGIES
Dec 12, 20242024/0408364Improved patches and methods for delivering an active substance to the skin using the sameMedical technologyDBV TECHNOLOGIES
Oct 17, 20242024/0342273IMMUNOTHERAPEUTIC METHOD FOR INCREASING CASHEW TOLERANCE IN A SUBJECTPharmaceuticalsDBV TECHNOLOGIES
Aug 8, 20242024/0261385OPTIMIZED EPICUTANEOUS VACCINATIONPharmaceuticalsDBV TECHNOLOGIES
Jun 6, 20242024/0181046ALLERGEN DESENSITIZATION METHODPharmaceuticalsDBV TECHNOLOGIES · patent 12,403,193 granted from it
Nov 9, 20232023/0355737PARTICLE COMPRISING AN RSV-F PROTEIN FOR USE IN RSV VACCINATIONPharmaceuticalsDBV TECHNOLOGIES
Dec 29, 20222022/0410188METHOD OF DEPOSITING A SUBSTANCE ON A SUBSTRATEOrganic fine chemistryDBV TECHNOLOGIES · patent 12,508,608 granted from it
Aug 4, 20222022/0241405ALLERGEN DESENSITIZATION METHODPharmaceuticalsDBV TECHNOLOGIES · patent 11,931,411 granted from it
Apr 29, 20212021/0121556OPTIMIZED EPICUTANEOUS VACCINATIONPharmaceuticalsDBV TECHNOLOGIES · patent 11,938,178 granted from it
Nov 12, 20202020/0353072ALLERGEN DESENSITIZATION METHODPharmaceuticalsDBV TECHNOLOGIES · patent 11,202,826 granted from it
What it applied for, 2024 to 2025: Pharmaceuticals 4 · Medical technology 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton DBVT · research, not advice